| Vikram Mehra, MD | |
|
21613 Provincial Blvd, Katy, TX 77450-6506 | |
| (713) 777-9900 | |
| (713) 777-9902 |
| Full Name | Vikram Mehra |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 31 Years |
| Location | 21613 Provincial Blvd, Katy, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801848957 | NPI | - | NPPES |
| 00476T | Other | TX | MEDICARE GROUP |
| 116322205 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | J6591 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vikram Mehra M.d.,p.a. | 8325080096 | 2 |
News Archive
13 October 2014, London and Oxford: The ABPI, which represents large, medium and small innovative research-based biopharmaceutical companies in the UK and OBN, the membership organisation that brings together the UK's emerging life sciences companies, corporate partners and investors are delighted to announce their commitment to working together under a Memorandum of Understanding (MoU).
BioSante Pharmaceuticals, Inc. today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante's common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million.
Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.
A research group under the leadership of Linköping University Professor Markus Heilig has identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops.
Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.
› Verified 2 days ago
| Entity Name | Deblin Health Concepts & Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063492320 PECOS PAC ID: 5193619930 Enrollment ID: O20040211001168 |
News Archive
13 October 2014, London and Oxford: The ABPI, which represents large, medium and small innovative research-based biopharmaceutical companies in the UK and OBN, the membership organisation that brings together the UK's emerging life sciences companies, corporate partners and investors are delighted to announce their commitment to working together under a Memorandum of Understanding (MoU).
BioSante Pharmaceuticals, Inc. today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante's common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million.
Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.
A research group under the leadership of Linköping University Professor Markus Heilig has identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops.
Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.
› Verified 2 days ago
| Entity Name | Vikram Mehra M.d.,p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821277708 PECOS PAC ID: 8325080096 Enrollment ID: O20050524000570 |
News Archive
13 October 2014, London and Oxford: The ABPI, which represents large, medium and small innovative research-based biopharmaceutical companies in the UK and OBN, the membership organisation that brings together the UK's emerging life sciences companies, corporate partners and investors are delighted to announce their commitment to working together under a Memorandum of Understanding (MoU).
BioSante Pharmaceuticals, Inc. today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante's common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million.
Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.
A research group under the leadership of Linköping University Professor Markus Heilig has identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops.
Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vikram Mehra, MD 21613 Provincial Blvd, Katy, TX 77450-6506 Ph: (713) 777-9900 | Vikram Mehra, MD 21613 Provincial Blvd, Katy, TX 77450-6506 Ph: (713) 777-9900 |
News Archive
13 October 2014, London and Oxford: The ABPI, which represents large, medium and small innovative research-based biopharmaceutical companies in the UK and OBN, the membership organisation that brings together the UK's emerging life sciences companies, corporate partners and investors are delighted to announce their commitment to working together under a Memorandum of Understanding (MoU).
BioSante Pharmaceuticals, Inc. today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante's common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million.
Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.
A research group under the leadership of Linköping University Professor Markus Heilig has identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops.
Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.
› Verified 2 days ago
Dr. Justin Patrick Morgan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 23900 Katy Fwy Ste 450, Katy, TX 77494 Phone: 713-486-7980 Fax: 713-486-8085 | |
Dr. Ankit Ashwin Patel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 507 Park Grove Ln, Katy, TX 77450 Phone: 281-206-2127 Fax: 281-206-2322 | |
Dr. Brian Zachariah, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 24275 Katy Fwy Ste 410, Katy, TX 77494 Phone: 877-504-8504 Fax: 855-420-6402 | |
Adenike Adigun, M.D, MPH Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24275 Katy Fwy Ste 410, Katy, TX 77494 Phone: 877-504-8504 Fax: 855-420-6402 | |
Dr. Melissa Sue Jones, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24514 Kingsland Blvd, Katy, TX 77494 Phone: 832-471-6248 Fax: 832-471-6984 | |
Ramana Surya, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 24530 Kingsland Blvd Ste B, Katy, TX 77494 Phone: 832-321-5180 Fax: 832-321-4497 | |
Dr. Jontel D Pierce, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2043 N Mason Rd Ste 704, Katy, TX 77449 Phone: 281-402-9522 |